Screener
Aquestive Therapeutics, Inc. AQST Contract Liabilities, Non-Current
Contract Liabilities, Non-Current at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000042
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Royalty obligations, net | 27,835 | 25,941 |
| Liability related to the sale of future revenue, net | 61,168 | 62,023 |
| Lease liabilities | 7,525 | 4,337 |
| Deferred revenue, net of current portion | 18,845 | 19,390 |
| Other non-current liabilities | 6,185 | 7,269 |
| Total liabilities | 188,690 | 194,087 |
| Contingencies (Note 20) | ||
| Stockholders’ deficit: |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Aquestive Therapeutics, Inc.'s contract liabilities, non-current?
- Aquestive Therapeutics, Inc. (AQST) reported contract liabilities, non-current of $18.85M in Q2 2026.
- How has Aquestive Therapeutics, Inc.'s contract liabilities, non-current changed year-over-year?
- Aquestive Therapeutics, Inc.'s contract liabilities, non-current decreased by 5.5% year-over-year, from $19.94M to $18.85M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s contract liabilities, non-current?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s contract liabilities, non-current has grown at a 39.8% compound annual growth rate (CAGR), from $3.63M to $19.39M.
- What does contract liabilities, non-current mean?
- Obligation to transfer goods or services for which payment has been received, expected to be satisfied beyond one year.
Ask your AI about Aquestive Therapeutics, Inc.'s contract liabilities, non-current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude